All Stories

  1. A Machine Learning Approach to Predict Mortality in Patients Enrolled in Cardiac Rehabilitation After Percutaneous Coronary Intervention for Acute Coronary Syndrome
  2. Does fatigue in patients with Post-COVID-19 Syndrome improve with rehabilitation?
  3. A machine learning approach predicts improvement of physical exercise capacity based on pulse wave analysis in coronary artery disease patients
  4. A Rule-Based decision support system (DSS) for safe and personalized physical exercise prescription in Cardiac Rehabilitation: Design, methodology, and validation. (Preprint)
  5. Assessment of dynamic cerebral blood flow changes during cognitive tasks in patients with post-COVID-19 syndrome
  6. microRNAs in Physical Exercise and Cardiovascular Disease
  7. Post-COVID-19 Syndrome
  8. A Machine Learning Approach to Predict Mortality in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention
  9. Development of Machine Learning Models for Predicting Effectiveness and Adherence in Cardiac Rehabilitation
  10. Autonomic dysfunction and vasoregulation in Long COVID-19 are linked to anti-GPCR autoantibodies
  11. Biomarker-based risk assessment of dietary intervention in patients with coronary artery disease during cardiac rehabilitation—a quasi-experimental study
  12. Design and validation of an energy level diary for fatigue management in patients with post-COVID syndrome
  13. Use of speleotherapy in patients with post-COVID-19 syndrome
  14. Characterization of a periodontal-inflammatory microRNA profile during multibracket orthodontic treatment in adolescents
  15. Retinal vessel density and cognitive function in healthy older adults
  16. Use of large language models to identify pseudo‐information: Implications for health information
  17. Self-rated physical fitness predicts cardiovascular and all-cause mortality—implications for clinical decision-making
  18. Time Course of Inflammatory and Endocrine Factors Following a Single-Bout of High-Intensity WB-EMS – A Randomized Crossover Study
  19. No impairment of maximal oxygen uptake in patients diagnosed with long COVID?
  20. Encyclopedia of Exercise Medicine in Health and Disease
  21. Effectiveness of behavior change techniques in eHealth-based cardiac rehabilitation in patients with coronary artery disease: A systematic review
  22. Detecting Atrial Fibrillation from Reduced-Lead Electrocardiograms of Mobile Patches Using Interpretable Features
  23. Inter-individual differences in muscle damage following a single bout of high-intense whole-body electromyostimulation
  24. Characterization of a periodontal-inflammatory microRNA profile during long-term multibracket orthodontic treatment in adolescents - a split-mouth design study
  25. Sex-specific differences of cardiopulmonary fitness and pulmonary function in exercise-based rehabilitation of patients with long-term post-COVID-19 syndrome
  26. Analysis of fat oxidation capacity during cardiopulmonary exercise testing indicates long-lasting metabolic disturbance in patients with Post-COVID-19 Syndrome
  27. Patient-reported preferences in eHealth-based cardiac rehabilitation: A qualitative investigation of behavior change techniques, barriers and facilitators
  28. Living Lab Data of Patient Needs and Expectations for eHealth-Based Cardiac Rehabilitation in Germany and Spain From the TIMELY Study: Cross-Sectional Analysis
  29. A behavioral change-based eHealth program for Promoting Regular Physical Activity in Medical Rehabilitation Maintenance: the RehaPlus+ concept (Preprint)
  30. A Behavioral Change-Based Mobile Intervention for Promoting Regular Physical Activity in Medical Rehabilitation Maintenance of Patients With Coronary Artery Disease: a Controlled Trial (Preprint)
  31. Non-coding RNAs in exercise immunology: A systematic review
  32. Living Lab Data of Patient Needs and Expectations for eHealth-Based Cardiac Rehabilitation in Germany and Spain From the TIMELY Study: Cross-Sectional Analysis (Preprint)
  33. Medical Rehabilitation of Patients with Post-COVID-19 Syndrome—A Comparison of Aerobic Interval and Continuous Training
  34. Autonomic dysregulation in long-term patients suffering from Post-COVID-19 Syndrome assessed by heart rate variability
  35. Altered tissue oxygenation in patients with post COVID-19 syndrome
  36. eHealth for maintenance cardiovascular rehabilitation: a systematic review and meta-analysis
  37. 89. Jahrestagung der Deutsche Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e.V. (German Cardiac Society)
  38. TIMELY: Providing In-Time and Intelligent Support for Cardiovascular Rehabilitation with ’Patients and Practitioners in the Loop’ Interaction
  39. A single session of EMS training induces long-lasting changes in circulating muscle but not cardiovascular miRNA levels - A randomized crossover study
  40. Prognostic and therapeutic potential of microRNAs for fracture healing processes and non‐union fractures: A systematic review
  41. Improving accessibility of scientific research by artificial intelligence—An example for lay abstract generation
  42. Altered Tissue Oxygenation in Patients with Post COVID-19 Syndrome
  43. Corrigendum: Health benefits of probiotics in sport and exercise—Non-existent or a matter of heterogeneity? A systematic review
  44. Defining patients needs and expectations for eHealth-based cardiac rehabilitation in Germany and Spain: living lab data from the TIMELY study
  45. Patient-centered cardiac rehabilitation by AI-powered lifestyle intervention – the timely approach
  46. Patient-centered lifestyle intervention using artificial intelligence methodologies: The TIMELY project for cardiac rehabilitation
  47. Therapeutic Potential of Electromyostimulation (EMS) in Critically Ill Patients—A Systematic Review
  48. Health Benefits of Probiotics in Sport and Exercise - Non-existent or a Matter of Heterogeneity? A Systematic Review
  49. Regulation of antiatherogenic mir-126 by physical exercise
  50. Longitudinal choriocapillaris changes in the presence of reticular pseudodrusen
  51. Paracentral acute middle maculopathy following high-intensity interval training
  52. Four weeks of electromyostimulation improves muscle function and strength in sarcopenic patients: a three‐arm parallel randomized trial
  53. Sex-specific differences and long-term outcome of patients with coronary artery disease and chronic kidney disease: the Coronary Artery Disease and Renal Failure (CAD-REF) Registry
  54. Differential effects of high-intensity interval training (HIIT) on choriocapillaris perfusion in healthy adults and patients with type 1 diabetes mellitus (T1DM)
  55. Effect of high-intensity interval training in patients with type 1 diabetes on physical fitness and retinal microvascular perfusion determined by optical coherence tomography angiography
  56. Four weeks of high-intensity interval training (HIIT) improve the cardiometabolic risk profile of overweight patients with type 1 diabetes mellitus (T1DM)
  57. Yo-Yo Intermittent Recovery Level 1 Test for Estimation of Peak Oxygen Uptake: Use Without Restriction?
  58. Sex Differences in High-Intensity Interval Training–Are HIIT Protocols Interchangeable Between Females and Males?
  59. Progressive high-intensity interval training (HIIT) is not superior to unmodified non-progressive HIIT in an uncontrolled setting
  60. Correlation analysis of physical fitness and retinal microvasculature by OCT angiography in healthy adults
  61. Soluble adenylyl cyclase (sAC) regulates calcium signaling in the vascular endothelium
  62. Neutralising anti‐drug antibodies in Fabry disease can inhibit endothelial enzyme uptake and activity
  63. Normative Yo-Yo Intermittent Recovery Level 1 and Yo-Yo Intermittent Endurance Level 1 test values of boys aged 9–16 years
  64. A three-step approach identifies novel shear stress-sensitive endothelial microRNAs involved in vasculoprotective effects of high-intensity interval training (HIIT)
  65. Rare non-coding Desmoglein-2 variant contributes to Arrhythmogenic right ventricular cardiomyopathy
  66. Effects of high-intensity interval training on microvascular glycocalyx and associated microRNAs
  67. Optische Kohärenztomographie-Angiographie als zukünftiges Diagnostikum in der Sportmedizin?
  68. Mutation-specific Fabry disease patient-derived cell model to evaluate the amenability to chaperone therapy
  69. Genome-wide association study suggests impact of chromosome 10 rs139401390 on kidney function in patients with coronary artery disease
  70. Dose-Dependent Effect of Enzyme Replacement Therapy on Neutralizing Antidrug Antibody Titers and Clinical Outcome in Patients with Fabry Disease
  71. Neutralizing anti-drug antibodies in Fabry disease have no obvious clinical impact?
  72. P3819Rare non-coding desmoglein-2 variant contributes to arrhythmogenic right ventricular cardiomyopathy
  73. Circulating non-coding RNAs as functional markers to monitor and control physical exercise for the prevention of cardiovascular disease
  74. Commentary: MicroRNA-221/222 Family Counteracts Myocardial Fibrosis in Pressure Overload-Induced Heart Failure
  75. The Yo-Yo Intermittent Tests: A Systematic Review and Structured Compendium of Test Results
  76. Effects of high-intensity interval training on optic nerve head and macular perfusion using optical coherence tomography angiography in healthy adults
  77. Characterization of drug-neutralizing antibodies in patients with Fabry disease during infusion
  78. Circulating microRNAs as functional biomarkers in cardioprotective exercise – The SPORTIVA study
  79. HIIT effects on optic nerve head and macular perfusion by optical coherence tomography angiography
  80. Longer Work/Rest Intervals During High-Intensity Interval Training (HIIT) Lead to Elevated Levels of miR-222 and miR-29c
  81. Comment on “Epigenetics and cardiovascular regenerative medicine in the elderly”
  82. ZFP226 is a novel artificial transcription factor for selective activation of tumor suppressor KIBRA
  83. Promoter methylation inhibits expression of tumor suppressor KIBRA in human clear cell renal cell carcinoma
  84. Two-year outcome and risk factors for mortality in patients with coronary artery disease and renal failure: The prospective, observational CAD-REF Registry
  85. Yo-Yo IR1 vs. incremental continuous running test for prediction of 3000-m performance
  86. Impact of immunosuppressive therapy on therapy-neutralizing antibodies in transplanted patients with Fabry disease
  87. Dose-Response of High-Intensity Training (HIT) on Atheroprotective miRNA-126 Levels
  88. Salt-induced Na+/K+-ATPase-α/β expression involves soluble adenylyl cyclase in endothelial cells
  89. Uric acid and essential hypertension
  90. Renal function predicts long-term outcome on enzyme replacement therapy in patients with Fabry disease
  91. Physical Exercise in Patients with Fabry Disease – a Pilot Study
  92. Functional Promoter Variant in Desmocollin-2 Contributes to Arrhythmogenic Right Ventricular Cardiomyopathy
  93. Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variant
  94. Baseline Characteristics and Prescription Patterns of Standard Drugs in Patients with Angiographically Determined Coronary Artery Disease and Renal Failure (CAD-REF Registry)
  95. Differential response to endothelial epithelial sodium channel inhibition ex vivo correlates with arterial stiffness in humans
  96. PP.28.12
  97. Serum-Mediated Inhibition of Enzyme Replacement Therapy in Fabry Disease
  98. Thromboembolic events in Fabry disease and the impact of factor V Leiden
  99. Aldosterone signaling and soluble adenylyl cyclase—A nexus for the kidney and vascular endothelium
  100. Salt controls endothelial and vascular phenotype
  101. Cryptogenic stroke and small fiber neuropathy of unknown etiology in patients with alpha-galactosidase A-10T genotype
  102. Identification of Genetic Markers for Treatment Success in Heart Failure Patients: Insight From Cardiac Resynchronization Therapy
  103. Soluble Adenylyl Cyclase in Vascular EndotheliumNovelty and Significance
  104. Increased monocyte adhesion by endothelial expression of VCAM-1 missense variation in vitro
  105. Tissue-specific differences in the regulation of KIBRA gene expression involve transcription factor TCF7L2 and a complex alternative promoter system
  106. Interindividual Transcriptional Regulation of the Human biglycan Gene Involves Three Common Molecular Haplotypes
  107. Multifocal White Matter Lesions Associated with the D313Y Mutation of the α-Galactosidase A Gene
  108. Genetic Variants of the Renin-Angiotensin-Aldosterone System and Reverse Remodeling After Cardiac Resynchronization Therapy
  109. Association of left ventricular mass with the AGTR1 A1166C polymorphism
  110. Are Retinal Microvascular Phenotypes Associated With the 1675G/A Polymorphism in the Angiotensin II Type-2 Receptor Gene?
  111. Knowledge extraction in a population suffering from heart failure
  112. P422 PROFILING OF BIGLYCAN MOLECULAR PROMOTER HAPLOTYPES
  113. Identification and Functional Analyses of Molecular Haplotypes of the Human Osteoprotegerin Gene Promoter
  114. Molecular investigation of the functional relevance of missense variants of ICAM-1